UniProt ID | FLVC1_HUMAN | |
---|---|---|
UniProt AC | Q9Y5Y0 | |
Protein Name | Feline leukemia virus subgroup C receptor-related protein 1 | |
Gene Name | FLVCR1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 555 | |
Subcellular Localization |
Isoform 1: Cell membrane Multi-pass membrane protein. Isoform 2: Mitochondrion membrane Multi-pass membrane protein. |
|
Protein Description | Isoform 1: Heme transporter that exports cytoplasmic heme. It can also export coproporphyrin and protoporphyrin IX, which are both intermediate products in the heme biosynthetic pathway. Does not export bilirubin. Heme export depends on the presence of HPX and is required to maintain intracellular free heme balance, protecting cells from heme toxicity. Heme export provides protection from heme or ferrous iron toxicities in liver, brain, sensory neurons and during erythtopoiesis, a process in which heme synthesis intensifies. Causes susceptibility to FeLV-C in vitro.; Isoform 2: Heme transporter that promotes heme efflux from the mitochondrion to the cytoplasm. Essential for erythroid differentiation.. | |
Protein Sequence | MARPDDEEGAAVAPGHPLAKGYLPLPRGAPVGKESVELQNGPKAGTFPVNGAPRDSLAAASGVLGGPQTPLAPEEETQARLLPAGAGAETPGAESSPLPLTALSPRRFVVLLIFSLYSLVNAFQWIQYSIISNVFEGFYGVTLLHIDWLSMVYMLAYVPLIFPATWLLDTRGLRLTALLGSGLNCLGAWIKCGSVQQHLFWVTMLGQCLCSVAQVFILGLPSRIASVWFGPKEVSTACATAVLGNQLGTAVGFLLPPVLVPNTQNDTNLLACNISTMFYGTSAVATLLFILTAIAFKEKPRYPPSQAQAALQDSPPEEYSYKKSIRNLFKNIPFVLLLITYGIMTGAFYSVSTLLNQMILTYYEGEEVNAGRIGLTLVVAGMVGSILCGLWLDYTKTYKQTTLIVYILSFIGMVIFTFTLDLRYIIIVFVTGGVLGFFMTGYLPLGFEFAVEITYPESEGTSSGLLNASAQIFGILFTLAQGKLTSDYGPKAGNIFLCVWMFIGIILTALIKSDLRRHNINIGITNVDVKAIPADSPTDQEPKTVMLSKQSESAI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MARPDDEEG ------CCCCCCCCC | 31.54 | - | |
20 | Ubiquitination | APGHPLAKGYLPLPR CCCCCCCCCCCCCCC | 56.63 | - | |
22 | Phosphorylation | GHPLAKGYLPLPRGA CCCCCCCCCCCCCCC | 12.39 | 25884760 | |
33 | Ubiquitination | PRGAPVGKESVELQN CCCCCCCCCCEECCC | 47.23 | 21906983 | |
43 | Ubiquitination | VELQNGPKAGTFPVN EECCCCCCCCCCCCC | 61.93 | - | |
46 | Phosphorylation | QNGPKAGTFPVNGAP CCCCCCCCCCCCCCC | 29.62 | 28122231 | |
56 | Phosphorylation | VNGAPRDSLAAASGV CCCCCHHHHHHHHCC | 22.61 | 30243723 | |
61 | Phosphorylation | RDSLAAASGVLGGPQ HHHHHHHHCCCCCCC | 25.38 | 30243723 | |
69 | Phosphorylation | GVLGGPQTPLAPEEE CCCCCCCCCCCCHHH | 24.33 | 30243723 | |
90 | Phosphorylation | PAGAGAETPGAESSP CCCCCCCCCCCCCCC | 26.87 | 26657352 | |
95 | Phosphorylation | AETPGAESSPLPLTA CCCCCCCCCCCCCHH | 36.40 | 27732954 | |
96 | Phosphorylation | ETPGAESSPLPLTAL CCCCCCCCCCCCHHC | 23.20 | 27732954 | |
101 | Phosphorylation | ESSPLPLTALSPRRF CCCCCCCHHCCHHHH | 24.50 | 27732954 | |
104 | Phosphorylation | PLPLTALSPRRFVVL CCCCHHCCHHHHHHH | 17.56 | 24719451 | |
265 | N-linked_Glycosylation | VLVPNTQNDTNLLAC EECCCCCCCCCEEEE | 56.91 | UniProtKB CARBOHYD | |
273 | N-linked_Glycosylation | DTNLLACNISTMFYG CCCEEEEEHHHHHHC | 26.16 | UniProtKB CARBOHYD | |
322 | Ubiquitination | PPEEYSYKKSIRNLF CCHHHCHHHHHHHHH | 33.82 | 21906983 | |
323 | Ubiquitination | PEEYSYKKSIRNLFK CHHHCHHHHHHHHHH | 42.77 | - | |
398 | Phosphorylation | WLDYTKTYKQTTLIV HHCCCCCCCHHHHHH | 11.58 | 22210691 | |
401 | Phosphorylation | YTKTYKQTTLIVYIL CCCCCCHHHHHHHHH | 21.29 | 22210691 | |
417 | Phosphorylation | FIGMVIFTFTLDLRY HHHHHHHHHHCCCCC | 12.46 | 22210691 | |
419 | Phosphorylation | GMVIFTFTLDLRYII HHHHHHHHCCCCCEE | 19.12 | 22210691 | |
530 | Ubiquitination | GITNVDVKAIPADSP EEEEECEEECCCCCC | 35.81 | 21906983 | |
536 | Phosphorylation | VKAIPADSPTDQEPK EEECCCCCCCCCCCC | 31.63 | 30266825 | |
538 | Phosphorylation | AIPADSPTDQEPKTV ECCCCCCCCCCCCEE | 55.02 | 30266825 | |
543 | Ubiquitination | SPTDQEPKTVMLSKQ CCCCCCCCEEEECCC | 53.66 | - | |
544 | Phosphorylation | PTDQEPKTVMLSKQS CCCCCCCEEEECCCC | 23.12 | - | |
548 | Phosphorylation | EPKTVMLSKQSESAI CCCEEEECCCCCCCC | 15.56 | - | |
549 | Ubiquitination | PKTVMLSKQSESAI- CCEEEECCCCCCCC- | 54.61 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FLVC1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FLVC1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FLVC1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of FLVC1_HUMAN !! |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-536, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-56, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-536, AND MASS SPECTROMETRY. |